Funded Project Details - FY2021
|Title:|| A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness|
Nancy G. Klimas
|Congressional District Code:
||Clinical Science R&D
|| January 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
DESCRIPTION (provided by applicant): The proposed Phase III study follows a promising Phase I/II double-blind, placebo-controlled crossover study of CoQ10 in 46 veterans with Gulf War illness (GWI) who met both the Kansas and CDC case definitions who were treated with 100mg or 300mg of a high bioavailability CoQ10 (ubiquinone) product or placebo. The study, performed by Dr. Beatrice Golomb and her team at the San Diego VA, found a significant improvement in men with GWI vs. placebo using...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.